« Return to News | Study Conduct | CROs/Service Providers

Innovation and Global Clinical Trial Participation Are the Focus of CenterWatch’s Latest Special Report on China’s Drug Development Industry

Friday, October 2, 2009 06:06 AM

BOSTON—China’s new investments in its domestic pharma industry are beginning to drive growth and reforms that are stimulating a new drug development culture, according to CenterWatch’s latest special report, China: A New Era of Innovation in Drug Development.

 Scheduled for release in early October, the fifth report in CenterWatch’s clinical research series reveals the initial benefits of China’s efforts and the various reforms in progress, as well as a look at the further initiatives needed to make the country a major player in the drug development arena.

 “CenterWatch has analyzed how China’s regulatory reforms can spur innovation in the domestic drug development community, as well as benefit Big Pharma that want to include China in their global drug development programs,” says Sara Gambrill, senior editor at CenterWatch and author of the report. In addition, the report discusses Big Pharma’s long-range plans to invest in the research and development sector and the talent needed in the area to successfully run trials at a global level.

Other key takeaways include a list of select CROs in the region, an up-to-date pipeline of drugs currently in development, and several charts and figures that make this an important informational resource for sponsors and CROs seeking to expand their programs in the region.

For more information or to purchase China: A New Era of Innovation in Drug Development, visit the CenterWatch bookstore at http://store.centerwatch.com.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.